Pliant Therapeutics, Inc. Common Stock (NASDAQ: PLRX) last traded at $1.16, up 3.12% on the session. The quote above updates while this page is open; the figures below are drawn from Pliant Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Pliant Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker PLRX. Its market capitalisation is $71.52 million.
Valuation measures for Pliant Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $71.52M |
|---|---|
| Enterprise value | $89.59M |
| Price / book | 0.49 |
| Beta | 0.93 |
Trailing-twelve-month figures tagged in Pliant Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$92.29M |
| EPS (TTM) | -$1.48 |
| Return on equity | -62.81% |
| Cash | $24.88M |
Range and volume for PLRX over the past 52 weeks.
| 52-week high | $1.95 |
|---|---|
| 52-week low | $1.02 |
| Volume | 504.7K |
| Average volume | 525.4K |
| Previous close | $1.12 |
Dividend history for Pliant Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.